Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.830
-0.020 (-0.52%)
At close: Aug 21, 2026, 4:00 PM EDT
3.829
-0.002 (-0.04%)
After-hours: Aug 21, 2026, 6:33 PM EDT
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $292.22 million as of August 21, 2026. Its market cap has decreased by -17.77% in one year.
Market Cap
292.22M
Enterprise Value
-21.34M
1-Year Change
-17.77%
Ranking
Category
Stock Price
$3.83
ChartMarket Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has decreased from $301.64M to $292.22M, a decrease of -3.12%. That is a compound annual growth rate of -0.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 292.22M | -60.84% |
| Dec 31, 2025 | 746.12M | 194.32% |
| Dec 31, 2024 | 253.51M | -39.25% |
| Dec 29, 2023 | 417.30M | 10.13% |
| Dec 30, 2022 | 378.93M | -47.15% |
| Dec 31, 2021 | 716.95M | 124.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 312.37M |
| Cartesian Therapeutics | 309.51M |
| InflaRx | 297.68M |
| Bicycle Therapeutics | 296.77M |
| Fate Therapeutics | 293.56M |
| Anavex Life Sciences | 290.06M |
| Eledon Pharmaceuticals | 286.32M |
| Neumora Therapeutics | 284.66M |